Erratum: Expression of Concern: “Insulin-like growth factor I (IGF-1) deficiency ameliorates sex difference in cardiac contractile function and intracellular Ca2+ homeostasis” [Toxicology Letters 206 (2) (10 October 2011) 130–138] (S0378427411014147), (10.1016/j.toxlet.2011.07.001);Insulin-like growth factor I (IGF-1) deficiency ameliorates sex difference in cardiac contractile function and intracellular Ca2+ homeostasis

Toxicology Letters

Volumn 206, Issue 2, 2011, Pages 130-138

  Ceylan Isik, Asli F ^a   Li, Qun ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING SCHOOL OF PHARMACY   (United States)

Author keywords

Cardiomyocytes; IGF 1; SERCA; Sex

Indexed keywords

CALCIUM ION; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PHOSPHOLAMBAN; REGULATOR PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART WEIGHT; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SODIUM CALCIUM EXCHANGE;

MUS;

EID: 80052084806     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2024.04.009     Document Type: Erratum

References (52)

1. Arnal J.F., Fontaine C., Billon-Gales A., Favre J., Laurell H., Lenfant F., Gourdy P. Estrogen receptors and endothelium. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1506-1512.
2. Billon-Gales A., Fontaine C., Douin-Echinard V., Delpy L., Berges H., Calippe B., Lenfant F., Laurell H., Guery J.C., Gourdy P., Arnal J.F. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 2009, 120:2567-2576.
3. Broglio F., Fubini A., Morello M., Arvat E., Aimaretti G., Gianotti L., Boghen M.F., Deghenghi R., Mangiardi L., Ghigo E. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin. Endocrinol. (Oxf.) 1999, 50:417-430.
4. Bupha-Intr T., Wattanapermpool J., Pena J.R., Wolska B.M., Solaro R.J. Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R837-R843.
5. Ceylan-Isik A.F., Erdogan-Tulmac O.B., Ari N., Ozansoy G., Ren J. Effect of 17beta-oestradiol replacement on vascular responsiveness in ovariectomized diabetic rats. Clin. Exp. Pharmacol. Physiol. 2009, 36:e65-e71.
6. Ceylan-Isik A.F., LaCour K.H., Ren J. Gender disparity of streptozotocin-induced intrinsic contractile dysfunction in murine ventricular myocytes: role of chronic activation of Akt. Clin. Exp. Pharmacol. Physiol. 2006, 33:102-108.
7. Ceylan-Isik A.F., LaCour K.H., Ren J. Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus. J. Appl. Physiol. 2006, 100:1638-1646.
8. Ceylan-Isik A.F., Sreejayan N., Ren J. Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction. J. Mol. Cell. Cardiol. 2011, 50:107-116.
9. Chaler E.A., Meazza C., Guercio G., Maceiras M., Rivarola M.A., Laarej K., Pagani S., Areny G., Albertini R., Llinares V., Belgorosky A., Bozzola M. Serum IGF-I and IGFBP-3 reference values from a chemiluminescent assay in normal children and adolescents of hispanic and italian origin: presence of sexual dimorphism in IGF-I values. J. Pediatr. Endocrinol. Metab. 2009, 22:1127-1135.
10. Dash R., Frank K.F., Carr A.N., Moravec C.S., Kranias E.G. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J. Mol. Cell. Cardiol. 2001, 33:1345-1353.
11. Duan J., Esberg L.B., Ye G., Borgerding A.J., Ren B.H., Aberle N.S., Epstein P.N., Ren J. Influence of gender on ethanol-induced ventricular myocyte contractile depression in transgenic mice with cardiac overexpression of alcohol dehydrogenase. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2003, 134:607-614.
12. Elsherif L., Jiang Y., Saari J.T., Kang Y.J. Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion. Exp. Biol. Med. (Maywood) 2004, 229:616-622.
13. Fliegner D., Schubert C., Penkalla A., Witt H., Kararigas G., Dworatzek E., Staub E., Martus P., Ruiz Noppinger P., Kintscher U., Gustafsson J.A., Regitz-Zagrosek V. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R1597-R1606.
14. Garcia-Segura L.M., Arevalo M.A., Azcoitia I. Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. Prog. Brain Res. 2010, 181:251-272.
15. Ge W., Li Q., Turdi S., Wang X.M., Ren J. Deficiency of insulin-like growth factor 1 reduces vulnerability to chronic alcohol intake-induced cardiomyocyte mechanical dysfunction: role of AMPK. J. Cell. Mol. Med. 2010.
16. Gola M., Bonadonna S., Doga M., Mazziotti G., Giustina A. Cardiovascular risk in aging and obesity: is there a role for GH. J. Endocrinol. Invest. 2005, 28:759-767.
17. Grohe C., Kahlert S., Lobbert K., Stimpel M., Karas R.H., Vetter H., Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 1997, 416:107-112.
18. Gupta, N., Lustig, R.H., Kohn, M.A., McCracken, M., Vittinghoff, E., 2011. Sex differences in statural growth impairment in Crohn's disease: role of IGF-1. Inflamm. Bowel Dis.,in press, doi:10.1002/ibd.21617.
19. Jankowska E.A., Biel B., Majda J., Szklarska A., Lopuszanska M., Medras M., Anker S.D., Banasiak W., Poole-Wilson P.A., Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006, 114:1829-1837.
20. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm. IGF Res. 2003, 13:113-170.
21. Katayama T., Fujiwara N., Tsuruya Y. Factors contributing to left atrial enlargement in adults with normal left ventricular systolic function. J. Cardiol. 2010, 55:196-204.
22. Kim J.K., Pedram A., Razandi M., Levin E.R. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J. Biol. Chem. 2006, 281:6760-6767.
23. Kravtsov G.M., Kam K.W., Liu J., Wu S., Wong T.M. Altered Ca(2+) handling by ryanodine receptor and Na(+)-Ca(2+) exchange in the heart from ovariectomized rats: role of protein kinase A. Am. J. Physiol. Cell Physiol. 2007, 292:C1625-C1635.
24. Lee W.L., Chen J.W., Ting C.T., Ishiwata T., Lin S.J., Korc M., Wang P.H. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology 1999, 140:4831-4840.
25. Li Q., Ceylan-Isik A.F., Li J., Ren J. Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res. 2008, 11:725-733.
26. Li Q., Ren J. Influence of cardiac-specific overexpression of insulin-like growth factor 1 on lifespan and aging-associated changes in cardiac intracellular Ca2+ homeostasis, protein damage and apoptotic protein expression. Aging Cell 2007, 6:799-806.
27. Li Q., Yang X., Sreejayan N., Ren J. Insulin-like growth factor I deficiency prolongs survival and antagonizes paraquat-induced cardiomyocyte dysfunction: role of oxidative stress. Rejuvenation Res. 2007, 10:501-512.
28. Li S.Y., Du M., Dolence E.K., Fang C.X., Mayer G.E., Ceylan-Isik A.F., LaCour K.H., Yang X., Wilbert C.J., Sreejayan N., Ren J. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 2005, 4:57-64.
29. Liao Y., Cooper R.S., Mensah G.A., McGee D.L. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995, 92:805-810.
30. Liew R., Stagg M.A., MacLeod K.T., Collins P. Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current. Br. J. Pharmacol. 2004, 142:89-96.
31. Ling S., Komesaroff P., Sudhir K. Cellular mechanisms underlying the cardiovascular actions of oestrogens. Clin. Sci. (Lond.) 2006, 111:107-118.
32. Lombardi M., Mercuro G., Fini M., Rosano G.M. Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention. Fundam. Clin. Pharmacol. 2010, 24:699-705.
33. Marni F., Wang Y., Morishima M., Shimaoka T., Uchino T., Zheng M., Kaku T., Ono K. 17 beta-estradiol modulates expression of low-voltage-activated Ca(V)3.2 T-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes. Endocrinology 2009, 150:879-888.
34. Mathiyalagan P., Chang L., Du X.J., El-Osta A. Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle 2010, 9:612-617.
35. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340:1801-1811.
36. Ogah O.S., Bamgboye A.E. Correlates of left ventricular mass in hypertensive Nigerians: an echocardiographic study. Cardiovasc. J. Afr. 2010, 21:79-85.
37. Pedram A., Razandi M., Lubahn D., Liu J., Vannan M., Levin E.R. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Endocrinology 2008, 149:3361-3369.
38. Perez-Lopez F.R., Larrad-Mur L., Kallen A., Chedraui P., Taylor H.S. Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod. Sci. 2010, 17:511-531.
39. Ren J. Cardiac health and diabetes mellitus in women: problems and prospects. Minerva Cardioangiol. 2006, 54:289-309.
40. Ren J., Ceylan-Isik A.F. Diabetic cardiomyopathy: do women differ from men?. Endocrine 2004, 25:73-83.
41. Ren J., Hintz K.K., Roughead Z.K., Duan J., Colligan P.B., Ren B.H., Lee K.J., Zeng H. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1800-H1807.
42. Ren J., Kelley R.O. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity (Silver Spring) 2009, 17:1114-1123.
43. Ren J., Samson W.K., Sowers J.R. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell. Cardiol. 1999, 31:2049-2061.
44. Shirato S., Swan B.A. Women and cardiovascular disease: an evidentiary review. Medsurg. Nurs. 2010, 19:282-286. 306.
45. Skavdahl M., Steenbergen C., Clark J., Myers P., Demianenko T., Mao L., Rockman H.A., Korach K.S., Murphy E. Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H469-H476.
46. Tappia P.S., Dent M.R., Aroutiounova N., Babick A.P., Weiler H. Gender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomers. Can. J. Physiol. Pharmacol. 2007, 85:465-475.
47. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., LeRoith D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7324-7329.
48. Yakar S., Sun H., Zhao H., Pennisi P., Toyoshima Y., Setser J., Stannard B., Scavo L., Leroith D. Metabolic effects of IGF-I deficiency: lessons from mouse models. Pediatr. Endocrinol. Rev. 2005, 3:11-19.
49. Younes M., Honma N. Estrogen receptor beta. Arch. Pathol. Lab. Med. 2011, 135:63-66.
50. Zhang B., Turdi S., Li Q., Lopez F.L., Eason A.R., Anversa P., Ren J. Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: roles of Akt, mTOR, GSK3beta, and PTEN. Free Radic. Biol. Med. 2010, 49:1238-1253.
51. Zhang X., Ye G., Duan J., Chen A.F., Ren J. Influence of gender on intrinsic contractile properties of isolated ventricular myocytes from calmodulin-induced diabetic transgenic mice. Endocr. Res. 2003, 29:227-236.
52. Zhao P., Turdi S., Dong F., Xiao X., Su G., Zhu X., Scott G.I., Ren J. Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes. Shock 2009, 32:100-107.